HighVista Strategies »

S&p Global shares owned by HighVista Strategies

Quarter-by-quarter ownership of S&p Global (SPGI) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in S&p Global

Tip: Access up to 7 years of quarterly data

All positions including S&p Global held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in S&p Global by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.5M 3.8k 407.26

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Definium Therapeutics Com Shs (DFTX)
Immunovant (IMVT)
Praxis Precision Medicines I Com New (PRAX)
Relay Therapeutics (RLAY)
Alkermes SHS (ALKS)
Vaxcyte (PCVX)
Tango Therapeutics (TNGX)
Liquidia Corporation Com New (LQDA)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)
Enliven Therapeutics (ELVN)
Amylyx Pharmaceuticals (AMLX)

View all positions for HighVista Strategies

Top funds holding S&p Global

BlackRock
Vanguard Capital Management
State Street Corporation
TCI Fund Management
Morgan Stanley
Geode Capital Management
Vanguard Portfolio Management
Wellington Management Company
Eagle Capital Management
Norges Bank Investment Management
Capital Research and Management Company - Division 3
Curated Wealth Partners
Northern Trust
Ubs Global Asset Management Americas
Goldman Sachs Group

View all funds holding S&p Global